DEFN14A: Lifeway Foods Faces Shareholder Revolt Over Governance, Performance, and Nepotism Allegations

Concerned shareholders, including company founders, are launching a consent solicitation to replace Lifeway Foods' entire Board of Directors, citing failed governance, declining financial performance, and alleged nepotism.

Summary

• A group of concerned shareholders, led by Ludmila Smolyansky and Edward Smolyansky, who collectively control an estimated 23.2% of outstanding common stock, are soliciting written consents to replace Lifeway Foods' Board of Directors.
• The solicitation proposes four key actions: repealing any bylaw amendments made by the current Board since March 24, 2023; removing all current directors; electing seven new nominees (Ludmila Smolyansky, Edward Smolyansky, Richard Beleutz, Cindy Curry, Michael Leydervuder, George Sent, and Robert Whalen); and amending the bylaws to prohibit the company from employing immediate family members of the president or CEO.
• The concerned shareholders allege that the current Board has overseen significant corporate governance failures, including mishandling a credible acquisition offer from Danone North America, which proposed to acquire all outstanding shares for $25.00 per share (59% premium) and later $27.00 per share (72% premium), both of which were rejected.
• Concerns are raised about declining operating performance, with income from operations decreasing by 56% year-over-year in Q1 2025, operating expenses increasing by 19%, and operating margin falling from 7.9% to 3.4%.
• The solicitation highlights alleged nepotism, specifically the employment of Jason Burdeen, spouse of CEO Julie Smolyansky, as Chief of Staff with a 2024 compensation of $313,800, despite his lack of apparent qualifications for managerial control.
• The current Board is also criticized for granting CEO Julie Smolyansky approximately $8.5 million in cash and shares, equating to approximately 94% of the company's 2024 net income, despite shareholder opposition to her compensation at the 2024 annual meeting.

Sentiment

Score: 2

Explanation: The document expresses a highly critical and negative sentiment towards the current management and Board of Lifeway Foods, detailing significant failures in corporate governance, declining financial performance, and alleged self-enrichment and nepotism. The tone is one of urgent need for substantial change.

Positives

• Danone North America presented unsolicited offers to acquire all outstanding shares of the company for $25.00 per share (59% premium over 3-month VWAP) and later $27.00 per share (72% premium), indicating significant external valuation interest.
• The proposed slate of directors includes individuals with extensive experience in finance, investment banking, corporate leadership, and the food industry, aiming to bring independent oversight and strategic expertise.

Negatives

• Income from operations declined by 56% year-over-year in the first quarter of 2025.
• Operating expenses increased by 19% in Q1 2025, while net sales only increased by 3.3%.
• Operating margin declined significantly from 7.9% in Q1 2024 to 3.4% in Q1 2025.
• The Board rejected two acquisition offers from Danone North America at substantial premiums ($25.00 and $27.00 per share) without articulating a comparable strategic plan to unlock shareholder value.
• The company granted CEO Julie Smolyansky approximately $8.5 million in cash and shares, representing about 94% of the company's 2024 net income, despite over 40% of shareholders opposing her compensation at the 2024 annual meeting.
• The employment of Jason Burdeen, the CEO's spouse, as Chief of Staff with a 2024 compensation of $313,800 is cited as an example of nepotism and lack of independent oversight.
• The 2021 acquisition of Glen Oaks, a drinkable yogurt company, is criticized for lacking tangible assets and experiencing a 50% decline in revenue to date.
• Stock sales by CEO Julie Smolyansky and director Pol Sikar following significant declines in operating performance raise concerns about the Board's confidence in the company's outlook.

Risks

• The current Board may challenge the validity of shareholder consents, potentially delaying or preventing the effectiveness of the proposed actions.
• The Bylaws Restoration Proposal could repeal bylaw amendments that some shareholders might consider beneficial to them or the company.
• The company's alleged attempt to sever ties with Danone, a 25-year investor and strategic partner, may have negative market implications.
• Ongoing litigation, including Danone's lawsuit alleging breach of fiduciary duty and contract, and Mr. Smolyansky's indemnification dispute, could result in significant legal costs and reputational damage.
• The company's financial performance continues to decline, as evidenced by the Q1 2025 results, posing a risk to future profitability and shareholder value.

Future Outlook

The Concerned Shareholders believe that only a reconstituted Board with an independent committee tasked with assessing strategic alternatives and potentially re-engaging with Danone can produce a more favorable outcome for shareholders. The proposed new board intends to conduct a full review of the company's business, strategy, and strategic alternatives.

Management Comments

• "We believe the Company's shareholders will be best served by directors who are committed to safeguarding and promoting the best interests of all Lifeway shareholders."
• "We believe the Company's recent employment of Jason Burdeen, spouse of the Company's chief executive officer, is contrary to the best interests of the Company and its shareholders."
• "We believe the time for substantial change is now."
• "We believe that the combined CEO/Chair roles, while occupied by Ms. Smolyansky, has been a significant governance failure resulting in lack of independent oversight."
• "We believe that the questionable compensation awards granted to Ms. Smolyansky at the end of the year were in flagrant opposition to shareholder sentiment conveyed at the 2024 annual meeting."

Industry Context

Lifeway Foods is positioned as the largest producer and marketer of kefir in the U.S. and a significant player in the broader probiotic-based products and natural, better-for-you foods markets. The ongoing dispute with Danone, a long-term strategic partner and investor, highlights challenges in maintaining key industry relationships and navigating potential consolidation within the health food sector.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or benchmarks for financial performance or corporate governance practices, focusing instead on internal criticisms of Lifeway's current management and board.

Management Changes

Corporate Governance

Legal Proceedings

• Danone North America filed a lawsuit against the Company and each member of the Board in the Circuit Court of Cook County, Illinois, Law Division, alleging breach of fiduciary duty of loyalty by approving a share issuance to Julie Smolyansky in violation of the Shareholder Agreement, and alleging breach of contract by the Company and Julie Smolyansky.
• Edward Smolyansky filed a lawsuit against the Company in the Circuit Court of Cook County, Illinois, Chancery Division (the Indemnification Dispute), seeking indemnification for approximately $210,000 of expenses incurred in defending a prior lawsuit claim by the Company, which was voluntarily dismissed.

Related Party Transactions

• Jason Burdeen, spouse of CEO Julie Smolyansky, is employed by the Company as the CEO's Chief of Staff and earned total compensation of $313,800 in 2024.
• Julie Smolyansky was issued 283,337 shares of Common Stock on December 19, 2024, without the consent of Danone North America, which Danone alleges was in breach of the 1999 Shareholder Agreement.
• The Board granted Julie Smolyansky approximately $8.5 million in cash and shares, equating to approximately 94% of the Company's 2024 net income, in addition to her regular compensation package.

Stakeholder Impact

• Shareholders: Directly impacted by alleged poor financial results, rejection of premium acquisition offers, questionable compensation practices, and lack of independent oversight, leading to a consent solicitation to protect their interests.
• Employees: Potential impact from declining operating performance and strategic uncertainty, though not explicitly detailed.
• Customers: No direct impact mentioned, but potential long-term effects from strategic missteps or changes in product focus.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned, but potential long-term effects from declining financial health.
• Danone: As a significant investor and strategic partner, Danone is directly impacted by the alleged invalidation of the Shareholder Agreement and the rejection of its acquisition offers, leading to litigation.

Next Steps

• Shareholders are urged to sign, date, and return the WHITE consent card between July 8, 2025, and August 1, 2025 (or July 25, 2025 for street name holders).
• The Concerned Shareholders will deliver signed consents to Lifeway once the requisite number of shares is obtained.
• If the proposals are approved, the current Board will be removed, and the seven Nominees will be elected to serve as directors.
• The newly elected Board is expected to assess strategic alternatives, including potentially re-engaging with Danone regarding its acquisition offers.
• The new Board will evaluate and consider the reimbursement of the Concerned Shareholders' solicitation expenses (anticipated to be approximately $600,000).

Key Dates

Recommendation

Keywords

Lifeway Foods, Consent Solicitation, Proxy Fight, Corporate Governance, Board of Directors, Shareholder Activism, Financial Performance, Nepotism, Acquisition Offer, Danone, Kefir, Probiotic Products, SEC Filing, DEFN14A